HeartBeam Stock (NASDAQ:BEAT)

Forecast Ownership Financials Chart Transcripts

Previous Close

$1.61

52W Range

$0.91 - $3.48

50D Avg

$1.52

200D Avg

$1.67

Market Cap

$54.21M

Avg Vol (3M)

$98.35K

Beta

-0.65

Div Yield

BEAT Company Profile

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Nov 11, 2021

Website

BEAT Performance

BEAT Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-19.89M	$-15.31M	$-13.03M
Net Income	$-19.45M	$-14.64M	$-12.83M
EBITDA	$-19.89M	$675.00K	$-13.03M
Basic EPS	$-0.73	$-0.72	$-1.57
Diluted EPS	$-0.73	$-0.72	$-1.57

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q2 25Aug 13, 25 | 4:30 PM

Q1 25May 13, 25 | 4:30 PM

Q4 24Mar 13, 25 | 4:30 PM

Peer Comparison

Ticker	Company
OSTX	OS Therapies Incorporated
CUE	Cue Biopharma, Inc.
OTLK	Outlook Therapeutics, Inc.
LUNG	Pulmonx Corporation
NRXP	NRx Pharmaceuticals, Inc.
MNOV	MediciNova, Inc.
ICCM	IceCure Medical Ltd
TELA	TELA Bio, Inc.
QNTM	Quantum BioPharma Ltd.